Preclinical Efficacy and Safety of VEGF-Grab, a Novel Anti-VEGF Drug, and Its Comparison to Aflibercept-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preclinical Efficacy and Safety of VEGF-Grab, a Novel Anti-VEGF Drug, and Its Comparison to Aflibercept

Published:2020-11-16 Issue:13 Volume:61 Page:22
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Hong Hye Kyoung¹,Park Young Joo²,Kim Duk Ki³,Ryoo Na-Kyung⁴,Ko You-Jin¹,Park Kyu Hyung¹,Kim Ho Min³⁵,Woo Se Joon¹

Affiliation:

1. Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, Korea

2. Department of Ophthalmology, Kangwon National University Hospital, Chuncheon, Korea

3. Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea

4. Department of Ophthalmology, Veterans Health Service Medical Center, Seoul, Korea

5. Center for Biomolecular & Cellular Structure, Institute for Basic Science, Daejeon, Korea

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIF-1α–dependent regulation of angiogenic factor expression in Müller cells by mechanical stimulation;Experimental Eye Research;2024-10

2. Decellularized vascular matrix material -TEVG coated with PRP for anti-degradation and anti-inflammation;2024-05-14

3. PB101, a VEGF- and PlGF-targeting decoy protein, enhances antitumor immunity and suppresses tumor progression and metastasis;OncoImmunology;2023-09-20

4. FITC-Labeled RGD Peptides as Novel Contrast Agents for Functional Fluorescent Angiographic Detection of Retinal and Choroidal Neovascularization;Cells;2023-07-21

5. Bietti crystalline dystrophy complicated by choroidal neovascularization treated with a single dose of aflibercept;Oman Journal of Ophthalmology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3